FDA Completes Human Dura Mater Classification, Undeterred By CJD Threat
This article was originally published in The Gray Sheet
Executive Summary
FDA will classify human dura mater as a Class II device (with special controls), despite lingering concerns raised by cases of dura mater-transmitted Creutzfeldt Jakob Disease (CJD) abroad